Table 3.
Vaccination | Eligible participants (n) |
Eligible participants who were vaccinated n (%; 95% CI) |
Vaccination coverage in the general population (%) |
---|---|---|---|
COVID-19 | 103 | 100 (98.1; 93.9–99.6) | 76.5* |
Influenza (past year)a | 78 | 65 (83.33; 73.9–90.3) | 39.3** |
Pneumococcus (past 5 years)b | 78 | 49 (62.8; 51.8–72.9) | 17.6** |
Tetanus (past 10 years) | 103 | 47c (45.6; 36.2–55.3) | 53.9** |
Diphtheria (past 10 years) | 103 | 23c (22.3; 15.1–31.1) | 52.7** |
The reported frequencies are based on the number of persons eligible for the respective vaccination according to the recommendations of the German Society for Rheumatology and the German Standing Committee on Vaccination. The findings are compared to data obtained from the Association of Statutory Health Insurances from 2020/2021 (Kassenärztliche Vereinigungen, RKI Vaccination Surveillance);
patients ≥60 years of age, currently managed with immunosuppressive therapy, or diagnosed with specific comorbidities (chronic cardiovascular, liver, renal or lung disease and/or diabetes);
patients managed with immunosuppressive therapy;
patients were asked if they have been vaccinated in the past 5 years;
data obtained from the Robert-Koch institute,
data obtained from Rieck et al. (17).